Healthcare Sales & Marketing Network News: fenofibrate

Searching News Database: fenofibrate

HSMN NewsFeed - 19 Dec 2017
Disarm Therapeutics Appoints Peter Keller Chief Business Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 6 Jul 2016
Mylan Launches Generic Fenoglide(R) Tablets
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 17 Jul 2014
Salix and Pharming Announce FDA Approval of RUCONEST(R) for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Nov 2013
Salix Pharmaceuticals to Acquire Santarus
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 14 Feb 2013
Santarus Announces Commercial Launch of UCERIS (budesonide) Extended Release Tablets
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 10 Apr 2012
Santarus Appoints Alessandro E. Della Ch� and Matthew W. Strobeck to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Feb 2012
Santarus Announces FDA Acceptance of UCERIS New Drug Application for Induction of Remission of Active Ulcerative Colitis
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 13 Feb 2012
Santarus Announces Initiation of Phase IIIb Study with UCERIS in Patients with Mild or Moderate Active Ulcerative Colitis
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 6 Feb 2012
Santarus Begins Promoting Cholesterol-Lowering Product FENOGLIDE
Biopharmaceuticals

HSMN NewsFeed - 25 Jan 2012
New FDA Approved Labeling For VYTORIN(R) (Ezetimibe/Simvastatin) Includes Results From the Study of Heart and Renal Protection (SHARP) in Patients With Moderate to Severe Chronic Kidney Disease
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 23 Dec 2009
Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 28 Sep 2009
Abbott to Acquire Solvay Pharmaceuticals Business
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Aug 2009
Merck and Schering-Plough Resolve Previously Disclosed Civil Class Action Lawsuits Related to VYTORIN(R) (ezetimibe/simvastatin) and ZETIA(R) (ezetimibe)
Biopharmaceuticals Cardiology Litigation

HSMN NewsFeed - 4 Aug 2009
FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 17 Feb 2009
Cipher receives tentative FDA approval for extended-release tramadol capsules
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 11 Feb 2009
Oscient Pharmaceuticals Restructures Commercial Organization
Biopharmaceuticals

HSMN NewsFeed - 27 Oct 2008
Cipher appoints Vice-President of Portfolio Development and Licensing
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2008
Dr. Michael Beckert Steps Down as EVP and CMO of LifeCycle Pharma Effective December 31, 2008
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Aug 2008
LifeCycle Pharma Sells Fenoglide(TM) Royalty Stream to Cowen Healthcare Royalty Partners for up to USD 105 Million Including an Upfront Payment of USD 29 Million
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 6 Aug 2008
Cipher Pharmaceuticals announces U.S. distribution and supply agreement with Ranbaxy for CIP-ISOTRETINOIN
Biopharmaceuticals Distribution

HSMN NewsFeed - 30 Jul 2008
Oscient Pharmaceuticals Promotes Mark A. Glickman to Senior Vice President, Sales and Marketing
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 May 2008
Cipher provides regulatory update for CIP-TRAMADOL ER
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Feb 2008
Sciele Pharma and LifeCycle Pharma Announce U.S. Market Launch of Fenoglide(TM)
Biopharmaceuticals

HSMN NewsFeed - 21 Feb 2008
LifeCycle Pharma Launches Its First Product in the U.S.
Biopharmaceuticals

HSMN NewsFeed - 11 Feb 2008
Cipher provides CIP-TRAMADOL ER regulatory update
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Jan 2008
Merck and Schering-Plough Respond To Issues Raised About ENHANCE Clinical Trial
Biopharmaceuticals

HSMN NewsFeed - 21 Jan 2008
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults With Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 18 Jan 2008
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 19 Nov 2007
Merck/Schering-Plough Pharmaceuticals Provides Update on ENHANCE Trial
Biopharmaceuticals Cardiology

HSMN NewsFeed - 16 Oct 2007
Cipher appoints William C. Garriock Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Aug 2007
Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
Biopharmaceuticals

HSMN NewsFeed - 23 Aug 2007
Oscient Pharmaceuticals Names Aaron D. Berg Vice President of Marketing and Mark A. Glickman Vice President of Sales
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Aug 2007
Sciele Pharma and Lifecycle Pharma Announce FDA Approval of New Formulation of Fenofibrate in 120 Mg. and 40 Mg. Dosage Strengths
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 13 Aug 2007
Cipher provides CIP-ISOTRETINOIN regulatory update
Biopharmaceuticals

HSMN NewsFeed - 11 Jul 2007
ProEthic Pharmaceuticals Enters Into U.S. Licensing and Distribution Agreement for Lipofen
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 10 Jul 2007
Cipher Pharmaceuticals enters into U.S. licensing and distribution agreement for Lipofen
Biopharmaceuticals Licensing

HSMN NewsFeed - 23 Jun 2007
New Study Demonstrates Colesevelam HCl Lowers Both A1C and LDL Cholesterol in Patients With Uncontrolled Type 2 Diabetes Mellitus on Metformin-Based Regimen
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 12 Jun 2007
July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of FACTIVE(R) Tablets for Five-Day Treatment of Community-Acquired Pneumonia
Biopharmaceuticals

HSMN NewsFeed - 8 Jun 2007
Schering-Plough and Bayer Healthcare Announce Availability of ZETIA in Japan, the First Cholesterol-Lowering Agent With a Novel Mechanism of Action Approved in Japan in 18 Years
Biopharmaceuticals Regulatory

HSMN NewsFeed - 3 May 2007
Cipher Pharmaceuticals receives approvable letter from FDA for CIP-TRAMADOL ER
Biopharmaceuticals FDA

HSMN NewsFeed - 2 May 2007
FDA Approves Oscient Pharmaceuticals' FACTIVE(R) Tablets for Five-Day Treatment of Community-Acquired Pneumonia
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Apr 2007
Cipher Pharmaceuticals receives approvable letter from FDA for CIP-ISOTRETINOIN
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 18 Apr 2007
Schering-Plough Announces ZETIA Approved in Japan for Treatment of High Cholesterol
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Apr 2007
Sciele Begins to Enroll Patients in a Pivotal Phase III Clinical Trial for the Combination of Pravastatin and Fenofibrate
Biopharmaceuticals Cardiology

HSMN NewsFeed - 10 Apr 2007
Cipher Pharmaceuticals comments on Ortho-McNeil Citizen Petition
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 28 Mar 2007
Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to Include Ezetimibe Efficacy Data
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Mar 2007
Merck and Schering-Plough to Develop Another New Cholesterol Lowering Medicine
Biopharmaceuticals Cardiology

HSMN NewsFeed - 2 Mar 2007
Abbott Canada Launches Oscient Pharmaceuticals' FACTIVE Tablets in Canada
Biopharmacetuicals

HSMN NewsFeed - 22 Feb 2007
New Treatment Guidelines for Community-Acquired Pneumonia Highlight Utility of FACTIVE Tablets
Biopharmaceuticals

HSMN NewsFeed - 26 Jan 2007
Oscient Pharmaceuticals Completes Enrollment in Phase IV Trial of FACTIVE Tablets
Biopharmaceuticals

HSMN NewsFeed - 2 Jan 2007
Daiichi Sankyo, Inc. Announces Filing of Supplemental New Drug Application for WelChol in the Treatment of Type 2 Diabetes Mellitus
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 29 Dec 2006
Oscient Pharmaceuticals Amends FACTIVE License Agreement with LG Life Sciences
Biopharmaceuticals Licensing

HSMN NewsFeed - 27 Nov 2006
FDA Accepts as "Complete Response" Oscient Pharmaceuticals' Submission Following FACTIVE Approvable Letter for Five-Day CAP
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Nov 2006
New Study Confirms WelChol Improves Glycemic Control in Patients With Uncontrolled Type 2 Diabetes Mellitus on Insulin
Biopharmaceuticals

HSMN NewsFeed - 13 Nov 2006
First Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits
Biopharmacetuicals Cardiology

HSMN NewsFeed - 13 Nov 2006
WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
Biopharmaceuticals

HSMN NewsFeed - 6 Nov 2006
Abbott to Expand Presence in Lipid Management Market With Acquisition of Kos Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 13 Oct 2006
Data on FACTIVE(R) Tablets Short-Course Therapy in Patients with Co-Morbidities Presented at Annual Meeting of Infectious Diseases Society of America
Biopharmaceuticals

HSMN NewsFeed - 5 Oct 2006
Oscient Pharmaceuticals and Pfizer, S.A. de C.V. Announce Launch of FACTIVE(R) Tablets in Mexico
Biopharmaceuticals

HSMN NewsFeed - 22 Sep 2006
Oscient Pharmaceuticals Receives Approvable Letter from FDA for FACTIVE(R) Tablets for Five-Day Treatment of Community-Acquired Pneumonia
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Sep 2006
Oscient Pharmaceuticals Announces Results of FDA Advisory Committee Meeting for FACTIVE Tablets for the Treatment of Acute Bacterial Sinusitis
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Sep 2006
Oscient Pharmaceuticals and Auxilium Pharmaceuticals Agree to Conclude TESTIM(R) Co-Promotion Partnership
Biopharmaceuticals

HSMN NewsFeed - 21 Aug 2006
Oscient Pharmaceuticals Completes Acquisition of Cardiovascular Therapy ANTARA(R) 130mg (fenofibrate) Capsules
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 10 Aug 2006
Oscient Pharmaceuticals and Abbott Canada Enter into Commercialization Agreement for FACTIVE Tablets
Biopharmaceuticals

HSMN NewsFeed - 8 Aug 2006
Cipher appoints new Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jul 2006
Oscient Pharmaceuticals Agrees to Acquire Cardiovascular Therapy ANTARA(R) 130 mg (fenofibrate) Capsules From Reliant Pharmaceuticals
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 5 Jul 2006
Abbott and AstraZeneca Announce Collaboration to Develop and Commercialize CRESTOR(R) and Next-Generation TriCor(R) (ABT-335) Fixed-Dose Combination
Biopharmaceuticals Cardiology

HSMN NewsFeed - 29 Jun 2006
Cipher submits NDA for once-daily TRAMADOL formulation
Biopharmaceuticals

HSMN NewsFeed - 23 Jun 2006
Cipher appoints Vice President of Scientific Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jun 2006
FDA Approves New Indication for ZETIA(R) (ezetimibe) - Merck/Schering-Plough's Cholesterol Lowering Drug - For Administration in Combination with Fenofibrate, along With Diet
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Jan 2006
Cipher provides CIP-Tramadol ER update
Biopharmaceuticals

HSMN NewsFeed - 19 Jan 2006
Open-Label Study Shows No Significant Effects on the Pharmacokinetics of a Single Dose of TRIGLIDE(TM) (Fenofibrate) Tablets When Combined With Lipitor(R) (Atorvastatin) or Zocor(R) (Simvastatin)
Biopharmaceuticals

HSMN NewsFeed - 13 Jan 2006
Cipher receives FDA approval for CIP-Fenofibrate
Biopharmaceuticals FDA

Return to NewsFeed

Additional items found! 26

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 26 additional stories matching:
fenofibrate
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.